NextCure NXTC
NASDAQ NXTC
$6.40 +0.17 (+2.73%)
At close: Nov 13, 2026 · 4:00 PM EST

NextCure (NXTC) Research & Development (2018 - 2026)

Updated

NextCure (NXTC) recorded Research & Development of $4.54 million in Q3 2026, down 26.1% from $6.14 million a year earlier and down 38.9% from the prior quarter.

Analysis

NextCure (NXTC) Research & Development (2018 - 2026) Analysis & Trends

On a TTM basis, NextCure's Research & Development came in at $25.59 million as of Sep 30, 2026, down 45.6% year-over-year; for FY2025, it was $44.92 million, up 8.3% from FY2024.

  • Annual Research & Development has a five-year compound annual growth rate of -0.7% (FY2020 to FY2025).
  • Across earlier years, Research & Development came in at $41.49 million in FY2024 (-13.4%), $47.93 million in FY2023 (-11.6%), $54.2 million in FY2022 (+8.0%) and $50.19 million in FY2021 (+7.8%).
  • The Q3 2026 figure is the lowest quarterly Research & Development since Q2 2018.
  • On a year-over-year basis, Research & Development has declined for five consecutive quarters, with an average decline of 15.5% over the last eight quarters.
  • Peak year-over-year performance for Research & Development in the last five years was growth of 94.0% in Q2 2025, against a decline of 69.2% in Q2 2026 at the low end.
  • Per Business Quant, the preceding three quarters came in at $7.43 million (Q2 2026), $6.83 million (Q1 2026) and $6.8 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn 4.25 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 4.65 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 2.57 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn 4.54 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn 3.89 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 2.11 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn 1.61 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 3.02 Bn
10 NextCure 29.30 Mn -71.08 Mn - 4.54 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 4.54 Mn
Jun 30, 2026 7.43 Mn
Mar 31, 2026 6.83 Mn
Dec 31, 2025 6.80 Mn
Sep 30, 2025 6.14 Mn
Jun 30, 2025 24.09 Mn
Mar 31, 2025 7.90 Mn
Dec 31, 2024 8.90 Mn
Sep 30, 2024 8.77 Mn
Jun 30, 2024 12.42 Mn
Mar 31, 2024 11.40 Mn
Dec 31, 2023 11.83 Mn
Sep 30, 2023 11.01 Mn
Jun 30, 2023 13.45 Mn
Mar 31, 2023 11.65 Mn
Dec 31, 2022 12.82 Mn
Sep 30, 2022 13.53 Mn
Jun 30, 2022 12.83 Mn
Mar 31, 2022 15.02 Mn
Dec 31, 2021 12.26 Mn
API Access

NextCure Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=NXTC&period=max&api_key=YOUR_API_KEY